SYNC - YOGAYoga's Impact on Neurocardiogenic Syncope and Autonomic Dysfunction
Yoga
Autonomic Nervous System Diseases+9
+ Consciousness Disorders
+ Nervous System Diseases
Treatment Study
Summary
Study start date: June 1, 2012
Actual date on which the first participant was enrolled.This study focuses on neurocardiogenic syncope (NCS), a condition that causes temporary drops in blood pressure, leading to fainting spells. It's a common issue that doctors often see in outpatient settings. Usually, patients are helped with education about syncope, managing anxiety, and developing coping skills. The study aims to explore the role of Yoga in managing this condition. Yoga is known to relieve stress and anxiety, and it has also been found to improve cardiovascular function by lowering heart rate and blood pressure. The main goal of Yoga is to gain control over the autonomic nervous system, which regulates functions like heart rate, blood pressure, and breathing rate. The researchers propose that Yoga could potentially decrease the frequency of NCS episodes and alleviate associated symptoms. Participants in this study will engage in Yoga practice. The study will measure the changes in the frequency of fainting spells before and after Yoga. It will also evaluate the differences in the occurrence of various symptoms related to NCS before and after Yoga practice. The primary goal is to see if Yoga can indeed reduce the number of fainting episodes and improve the overall condition of individuals with NCS.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.8 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 60 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Diagnosis of recurrent Neurocardiogenic syncope At least one episode of syncope or pre-syncopal event in the last 3 months prior to enrollment Exclusion Criteria: Previously established diagnosis of any psychiatric illness. Previous history of Coronary Artery Disease, myocardial infarction, congestive heart failure, carotid sinus hypersensitivity Established diagnosis of tachy and/or brady arrhythmias, except cardioinhibiotry neurocardiogenic syncope. History of pacemaker, ICD or CRT-D implantation. Other conditions where Yoga should be avoided are: Pregnant women Subjects with untreated or uncontrolled high blood pressure Subjects with past history of Pnuemothorax. Subjects with severe cervical spondylitis and cervical, thoracic or lumbar disc prolapse. Subjects with carotid stenosis Subjects with history of psychosis (evidence of acute episodes with deep and prolonged meditation) or substance abuse. Subjects with the history of epilepsy ( evidence of acute episodes with deep and prolonged meditation) Subjects with glaucoma Subjects with history of Total Hip Replacement.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
University of Kansas Medical Center
Kansas City, United StatesOpen University of Kansas Medical Center in Google Maps